Trusted Resources: Education
Scientific literature and patient education texts
Identification and Structure Characterization of Novel IDS Variants Causing Mucopolysaccharidosis Type II: A Retrospective Analysis of 30 Chinese Children
source: Clinica chimica acta; international journal of clinical chemistry
year: 2021
authors: Zhao XY,Qiao GM,Liu F
summary/abstract:Mucopolysaccharidosis type II (MPS II) or Hunter syndrome is a rare X-linked recessive genetic disease resulting from deficient activity of the iduronate-2-sulfatase(IDS) enzyme and the accumulation of glycosaminoglycans in almost all cells, tissues and organs, which makes viscera function impaired.This study retrospectively analyzed the clinical characteristics, leukocyte IDS activity and mutations in the IDS gene of 30 Chinese children with MPS II.
organization: Department of Pediatrics, Hebei Medical University, Shijiazhuang 050000, Hebei, China.DOI: 10.1016/j.cca.2021.10.020
read more
BookmarkRelated Content
-
Hunter Syndrome – After Diagnosis: What Next?Talking About the Diagnosis It can be ha...
-
Convergent Molecular Mechanisms Underlying Cognitive Impairment in Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II) i...
-
Enzyme Replacement Therapy With Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis o...Enzyme replacement therapy (ERT) improve...
-
Golgi Requires a New Casting in the Screenplay of Mucopolysaccharidosis II CytopathologyLysosome (L), a hydrolytic compartment o...
-
Evaluation of the Long-Term Treatment Effects of Intravenous Idursulfase in Patients With Mucopolysaccharidosis II (...Mucopolysaccharidosis II (MPS II; Hunter...
-
Hunter Syndrome: OverviewHunter syndrome is a very rare, inherite...
-
Real World Long-Term Outcomes in Patients With Mucopolysaccharidosis Type II: A Retrospective Cohort StudyWe investigated the decline of activitie...
Powered by
